This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slid 3.0% to $6.45 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 17,928.92 and the Dow Jones Industrial Average falling 0.3% to 41,249.38.
Corbus Pharmaceuticals Holdings Inc. closed 89.6% below its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 6.4% to $3.95, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 1.08% to $27.55.
Trading volume totaled 126,292, compared to the 50-day average of 192,141.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 09, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.